HNB
KDNY

Huntington National Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Huntington National Bank’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4
Closed – – 1604
2016
Q2 		$0 Buy
+4
New +$243 ﹤0.01% 1714
2016
Q1 		– Sell
-3
Closed – – 1854
2015
Q4 		$0 Hold
3
– – ﹤0.01% 1719
2015
Q3 		$0 Hold
3
– – ﹤0.01% 1809
2015
Q2 		$0 Buy
+3
New +$495 ﹤0.01% 1841

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Huntington National Bank's KDNY Position: Q3 2016 in Review

Huntington National Bank sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2016, closing a stake of 4 shares.

Huntington National Bank first reported a position in KDNY in Q2 2015 and held it in 4 quarters. The position peaked at $0 in Q2 2016. 92 funds tracked by Wall St. Rank hold KDNY as of Q3 2016.

  • Huntington National Bank reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Huntington National Bank sold 4 Chinook Therapeutics, Inc. Common Stock shares in Q3 2016.
  • Huntington National Bank first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 4 quarters.
  • Huntington National Bank's Chinook Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2016.
  • 92 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Huntington National Bank's 13F filing for Q3 2016, filed 31 Oct 2016.